Hikma Pharmaceuticals Plc Doc re. Bond Guarantor Group (4851X)
May 06 2016 - 4:12AM
UK Regulatory
TIDMHIK
RNS Number : 4851X
Hikma Pharmaceuticals Plc
06 May 2016
6 May 2016
NOTICE OF ACCESSION OF GUARANTORS
Hikma Pharmaceuticals Public Limited Company
(the "Issuer")
Notice to the holders of the outstanding
U.S.$500,000,000 4.25 per cent. Guaranteed Notes due 2020 (ISIN:
XS1213834978)
(the "Notes")
The Issuer refers to (i) the terms and conditions of the Notes
(the "Conditions") set out in the prospectus dated 8 April 2015
relating to the Notes and (ii) a deed of guarantee dated 10 April
2015 between the Issuer and Arab Pharmaceutical Manufacturing PSC,
Eurohealth (USA), Inc., Hikma Farmacêutica (Portugal) S.A., Hikma
Pharmaceuticals LLC and West-Ward Pharmaceutical Corp. (together,
the "Original Guarantors") in favour of the Holders and the
Relevant Account Holders (each as defined therein) (the "Deed of
Guarantee").
Capitalised terms used in this Notice and not defined herein
shall have the meanings set out in the Conditions and the Deed of
Guarantee.
NOTICE IS HEREBY GIVEN that, pursuant to and in compliance with
the provisions of Condition 5.7 (Guarantor Group) and the Deed of
Guarantee, as of 29 April 2016 each of the subsidiaries of the
Issuer listed in the Schedule to this Notice has, in each case,
pursuant to an accession deed of guarantee dated 29 April 2016
(each an "Accession Deed of Guarantee") and an accession deed of
covenant dated 29 April 2016, become a Guarantor and agreed to:
(i) perform and observe all the obligations expressed to be
undertaken by a Guarantor under the Conditions, the Deed of
Guarantee, a deed of covenant between the Issuer and the Original
Guarantors dated 10 April 2015 (the "Deed of Covenant") and a
fiscal agency agreement between, among others, the Issuer, the
Original Guarantors and Citbank, N.A. London Branch dated 10 April
2015 ("the Fiscal Agency Agreement"), and each agrees that it shall
be bound by the Conditions, the Deed of Guarantee, the Deed of
Covenant and the Fiscal Agency Agreement in all respects as if it
had been an original party thereto; and
(ii) jointly and severally with all the Original Guarantors,
unconditionally and irrevocably guarantee the payment of all sums
expressed to be payable by the Issuer in respect of the Notes to
Holders and Relevant Account Holders.
Copies of each Accession Deed of Guarantee (and the documents
described therein) are available for inspection at the office of
Hikma Pharmaceuticals Public Limited Company.
Schedule
Name of New Guarantor Registration Address
-------------------------------------------------------- ------------------------------------ -----------------
Roxane Laboratories, Inc. (entity number E0034412005-8) Registered in the state of Nevada 1809 Wilson Road
Columbus
OH 43228
United States
-------------------------------------------------------- ------------------------------------ -----------------
West-Ward Columbus Inc (file number 863458) Registered in the state of Delaware
-------------------------------------------------------- ------------------------------------ -----------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
DOCUGUUGAUPQURQ
(END) Dow Jones Newswires
May 06, 2016 04:12 ET (08:12 GMT)
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jul 2023 to Jul 2024